Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
38
MIST Quote, Financials, Valuation and Earnings
Last price:
$2.08
Seasonality move
:
-12.37%
Day range:
$1.90 - $2.10
52-week range:
$0.63 - $3.06
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
8.10x
Volume:
6.4M
Avg. volume:
8.1M
1-year change:
11.89%
Market cap:
$166.1M
Revenue:
--
EPS (TTM):
-$0.86
Earnings Data
Next earnings date for MIST
Mar 12
2026
Most recent earnings per share
-$0.12
Beat by $0.04
(Nov 12/2025)
Consensus Estimate
-$0.17
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MIST Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/12/2026 | Q4 | -- | -- | -- | -$0.18 | -- |
| 11/12/2025 | Q3 | -- | -- | -$0.12 | -$0.17 | $0.04 |
| 08/12/2025 | Q2 | -- | -- | -$0.20 | -$0.18 | -$0.02 |
| 05/12/2025 | Q1 | -- | -- | -$0.31 | -$0.20 | -$0.12 |
| 03/13/2025 | Q4 | -- | -- | -$0.23 | -$0.15 | -$0.08 |
| 11/12/2024 | Q3 | -- | -- | -$0.14 | -$0.18 | $0.04 |
| 08/08/2024 | Q2 | -- | -- | -$0.14 | -$0.20 | $0.06 |
| 05/13/2024 | Q1 | -- | -- | -$0.21 | -$0.27 | $0.06 |
| 03/21/2024 | Q4 | -- | -- | -$0.32 | -$0.33 | $0.01 |
| 11/13/2023 | Q3 | -- | -- | -$0.35 | -$0.39 | $0.04 |
| 08/10/2023 | Q2 | -- | -- | -$0.37 | -$0.39 | $0.02 |
| 05/11/2023 | Q1 | -- | -- | -$0.35 | -$0.40 | $0.05 |
| 03/29/2023 | Q4 | -- | -- | -$0.31 | -$0.31 | -- |
| 11/10/2022 | Q3 | -- | -- | -$0.34 | -$0.42 | $0.08 |
| 08/10/2022 | Q2 | -- | -- | -$0.39 | -$0.37 | -$0.02 |
| 05/12/2022 | Q1 | -- | -- | -$0.33 | -$0.38 | $0.05 |
| 03/24/2022 | Q4 | -- | -- | -$0.40 | -$0.36 | -$0.04 |
| 11/12/2021 | Q3 | -- | -- | -$0.34 | -$0.35 | $0.01 |
| 08/11/2021 | Q2 | -- | -- | $0.02 | -$0.35 | $0.37 |
| 05/17/2021 | Q1 | -- | -- | -$0.30 | -$0.33 | $0.03 |
| 03/29/2021 | Q4 | -- | -- | -$0.13 | -$0.42 | $0.29 |
| 11/13/2020 | Q3 | -- | -- | -$0.40 | -$0.46 | $0.06 |
| 08/12/2020 | Q2 | -- | -- | -$0.53 | -$0.43 | -$0.10 |
| 05/14/2020 | Q1 | -- | -- | -$0.67 | -$0.74 | $0.07 |
| 03/06/2020 | Q4 | -- | -- | -$0.75 | -$0.59 | -$0.16 |
| 11/13/2019 | Q3 | -- | -- | -$0.52 | -$0.55 | $0.03 |
| 08/13/2019 | Q2 | -- | -- | -$0.56 | -$0.56 | $0.00 |
Milestone Pharmaceuticals, Inc. Earnings Questions
-
How Much did Milestone Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
Milestone Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did Milestone Pharmaceuticals, Inc. Beat Earnings Last Quarter?
Milestone Pharmaceuticals, Inc. announced earnings per share of -$0.12 which represents a beat of analyst forecast a -$0.17 per share.
-
Is Milestone Pharmaceuticals, Inc. Profitable?
Milestone Pharmaceuticals, Inc. reported -$25K that represents -$0.00 per share over the last quarter.
-
What is the Analyst Consensus for Milestone Pharmaceuticals, Inc. EPS Next Year?
Milestone Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$0.67 per share to -$0.61 per share next year representing a decrease of -6.88%.
-
When is Milestone Pharmaceuticals, Inc.'s Earnings Date?
Milestone Pharmaceuticals, Inc.'s next earnings date is March 12, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
